Description
Diocor Solo 160 (Valsartan, Hydrochlorothiazide) Coated Tablets 160 mg. №10
Composition
Active ingredients: Valsartan 160 mg, Hydrochlorothiazide 12.5 mg.
Mechanism of Action
Pharmacological Properties: Valsartan is an angiotensin II receptor blocker that relaxes blood vessels, while hydrochlorothiazide is a diuretic that reduces the amount of water in the body by increasing urine flow. The combined action of these ingredients helps lower blood pressure by reducing fluid retention and dilating blood vessels.
Indications for Use
Indicated for: Treatment of hypertension in patients whose blood pressure is not adequately controlled on monotherapy.
Contraindications
Do not use if: Allergic to any component, pregnant, severe renal impairment.
Side Effects
- Dizziness
- Hypotension
- Electrolyte imbalances
Usage Instructions
Dosage: 1 tablet daily, or as prescribed by a healthcare professional. Take Diocor Solo 160 exactly as prescribed. Swallow the tablet whole with water, with or without food.
Benefits Compared to Analogues
Studies have shown that the combination of valsartan and hydrochlorothiazide in Diocor Solo 160 provides better blood pressure control compared to monotherapy. Research published in the Journal of Clinical Hypertension demonstrated a significant reduction in both systolic and diastolic blood pressure with this combination therapy.
Suitable Patient Groups
Diocor Solo 160 is suitable for adult patients with hypertension who require combination therapy for better blood pressure control.
Storage and Shelf Life
Storage: Store at room temperature away from moisture and heat.
Packaging Description
Diocor Solo 160 comes in coated tablets of 160 mg, packed in a box containing 10 tablets.
Clinical Evidence and Proven Effectiveness
Clinical trials have shown that the combination of valsartan and hydrochlorothiazide is more effective in lowering blood pressure compared to either drug alone. A study published in the American Journal of Hypertension reported a greater reduction in blood pressure and improved cardiovascular outcomes with this combination therapy.
